Bristol-Myers Squibb Company (ETR: BRM)
Germany
· Delayed Price · Currency is EUR
50.78
-1.71 (-3.26%)
Nov 7, 2024, 5:35 PM CET
BRM Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2023. The number of employees decreased by 200 or -0.58% compared to the previous year.
Employees
34,100
Change (1Y)
-200
Growth (1Y)
-0.58%
Revenue / Employee
€1,247,221
Profits / Employee
€190,836
Market Cap
102.87B
Employees Chart
Employees History
Bristol-Myers Squibb Company News
- 3 days ago - Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Benzinga
- 3 days ago - How Is The Market Feeling About Bristol-Myers Squibb? - Benzinga
- 5 days ago - Bristol-Myers Squibb's Cobenfy Shows Sustained Efficacy in Schizophrenia Treatment - GuruFocus
- 6 days ago - Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade - Investor's Business Daily
- 6 days ago - Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious - Benzinga
- 7 days ago - Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY (xanomeline and trospium chloride) in Adults with Schizophrenia at Psych Congress 2024 - Wallstreet:Online
- 7 days ago - Bristol-Myers Squibb Company (BMY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript - The Motley Fool